Results 161 to 170 of about 52,329 (268)
The role of cancer‐associated fibroblasts in the tumour microenvironment of urinary system
We summarised the role of cancer‐associated fibroblasts (CAFs) in urological tumours, including their origin, exosomes and extracellular matrix (ECM). CAFs are derived from various precursor cells and can communicate with other cells to form a hypoxic and immunosuppressive microenvironment.
Ri Hong+7 more
wiley +1 more source
Opportunistic Gulls Infected by Antibiotic‐Resistant Bacteria Show Contrasting Movement Behaviour
Our work addresses a major research gap in animal ecology and movement behaviour by investigating differences between infected and uninfected gull individuals with Escherichia coli. More specifically, we investigated differences in movement metrics by using high‐resolution GPS movement data.
Víctor Martín‐Vélez+8 more
wiley +1 more source
Isolation and characterization of bacteriophage against clinical isolates of AmpC beta lactamase-Producing Klebsiella pneumoniae from hospital wastewater. [PDF]
Abusalah MAHA+4 more
europepmc +1 more source
Role of Bacteroides bivius beta-lactamase in beta-lactam susceptibility [PDF]
Jacques Lacroix+2 more
openalex +1 more source
Antimicrobial resistance and new viral strains are rising threats. Metal‐based nanomaterials show promise but have side effects and debated effectiveness. A metal‐free approach using nitrogen‐doped graphene acid activated by near‐infrared light is proposed, achieving significant reductions in bacterial and viral spread without adverse effects, offering
Giacomo Reina+11 more
wiley +1 more source
From Diarrhea to Bacteremia: Extended-Spectrum Beta-Lactamase (ESBL)-Producing Shigella in a Rare Clinical Scenario. [PDF]
Al-Anbagi U+7 more
europepmc +1 more source
Staphylococcus saprophyticus beta-lactamase production and disk diffusion susceptibility testing for three beta-lactam antimicrobial agents [PDF]
Robert H. Latham+4 more
openalex +1 more source
Novel inhibitors of beta-lactamase [PDF]
Vitaly G. Grigorenko+8 more
openaire +2 more sources
This study investigates the risk of serious infections (SIs) in patients treated with biologic or targeted‐synthetic disease‐modifying antirheumatic drugs (b/tsDMARDs) in Qatar. Out of 1092 patients, 86 (7.9%) experienced SIs, with adalimumab and infliximab associated with higher SI rates.
Sreethish Sasi+12 more
wiley +1 more source